Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Poly-Refractory Rheumatoid Arthritis: An Uncommon Subset of a Difficult-to-Treat Disease

Arthritis & Rheumatology  |  March 26, 2024

Difficult-to-treat rheumatoid arthritis (RA) is defined as the failure of two or more classes of biologic or targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs) to control active or progressive disease in patients with RA. Between 5 and 20% of patients with RA have difficult-to-treat RA.

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:Arthritis & RheumatologyRA Resource CenterResearchRheumatoid Arthritis (RA)

FDA Proposal for Biosimilar Use in 2025 Budget

Michele B. Kaufman, PharmD, BCGP  |  March 26, 2024

A proposal for biosimilar use in the 2025 budget would allow substitution of any biosimilar for its reference product without an interchangeable designation. The hope is to increase biosimilar uptake, with the subsequent potential to increase product “competition, access and affordability.”1 In the 2025 budget proposal, the Biden administration noted that the legal distinction between…

Filed under:Biologics/DMARDsDrug UpdatesLegislation & AdvocacyProfessional Topics Tagged with:Biosimilarsinterchangeability

The Biases We Don’t Know We Hold

Vanessa Caceres  |  March 26, 2024

Implicit bias can affect patient care at the physician level when they’re making treatment decisions and at the healthcare organization level when they’re choosing new hires. Here are insights into strategies rheumatologists can use to become aware of, and question, their implicit biases.

Filed under:OpinionPractice ManagementWorkforce Tagged with:biasdiscriminationEquityinclusion

Mental Health in Rheumatology

Vanessa Caceres  |  March 26, 2024

Regaining a sense of control, limiting responsibilities and engaging in mindfulness can help rheumatologists manage their mental health needs. Rheumatologists should also address the mental health concerns raised by their patients. Here are insights from a psychiatrist/rheumatologist.

Filed under:ConditionsOther Rheumatic Conditions Tagged with:burnoutMental Health

Representation of the molecular structure of interferon a.

Interferons in Systemic Lupus Erythematosus

Katie Robinson  |  March 21, 2024

Current knowledge of receptor-ligand interactions, cell signaling, and transcriptional regulation derive from studies of type I interferon. The design of novel therapeutics is informed by the advances in investigation of type I interferon, with the potential for important impacts on patient management.

Filed under:American College of RheumatologyConditionsResearch ReviewsResearch RheumSystemic Lupus Erythematosus Tagged with:Arthritis & RheumatologyImmunologyinterferon

Focus on Community Practice Rheumatology

Vanessa Caceres  |  March 14, 2024

Community practice rheumatology brings with it certain challenges, but it also offers rewards, such as autonomy and the capacity to develop deep relationships with patients. Three rheumatologists discuss the challenges and rewards of private practice.

Filed under:American College of RheumatologyOpinionPractice ManagementPractice Support

Congressional Action Partially Addresses Medicare Cuts

From the College  |  March 7, 2024

The newest funding package reduces the latest cut to Medicare reimbursement from 3.4% to 1.68%. Although rheumatologists are faring better under Medicare in 2024, broader reforms remain the ACR’s highest priority regarding Medicare payments to physicians.

Filed under:Billing/CodingLegislation & Advocacy Tagged with:ACR advocacyMedicare Reimbursement

Sharad Lakhanpal, MBBS, MD, Named an APLAR Master

Gretchen Henkel  |  March 7, 2024

In early December, Sharad Lakhanpal, MBBS, MD, a rheumatologist at Rheumatology Associates in Dallas and past president of the ACR, traveled to Chiang Mai, Thailand, for the 2023 Congress of the Asia Pacific League of Associations for Rheumatology (APLAR). There he was named an APLAR Master. The award is presented to someone not from APLAR,…

Filed under:AwardsCareer Tagged with:APLARAPLAR Asia PacificAsia Pacific League of Associations for Rheumatology (APLAR)Dr. Sharad LakhanpalMovers & Shakers

The Roles of the Interdisciplinary Rheumatology Team in Patient Care Highlighted

Kimberly Steinbarger, PT, MHS, DHSc, & Keri Losavio  |  March 4, 2024

To work together effectively, clinicians and rheumatology professionals need to understand the roles of every member of the interdisciplinary team. To enhance this understanding, the ARP Interprofessional Practice & Management Committee has undertaken a project to describe the modern roles of members of the interdisciplinary team in a series of fact sheets. The first three…

Filed under:American College of RheumatologyInterprofessional PerspectivePractice ManagementPractice SupportProfessional TopicsWorkforce Tagged with:fact sheets

Can Repeat Injections Improve Knee OA Pain?

Michele B. Kaufman, PharmD, BCGP  |  March 1, 2024

Promising Results from a Phase 3 Study SAN DIEGO—An investigational liposomal formulation of dexamethasone sodium phosphate (TLC599) for intra-articular injection is being studied to treat patients with knee osteoarthritis (OA). George Spencer-Green, MD, MS, chief medical officer of Taiwan Liposome Company (TLC), Cambridge, Mass., presented recent data on this agent in a late-breaking abstract session…

Filed under:ACR ConvergenceAnalgesicsConditionsDrug UpdatesMeeting ReportsOsteoarthritis and Bone Disorders Tagged with:ACR Convergence 2023corticosteroid injectionKnee Osteoarthritis (OA)

  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 323
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences